Ftse Mib
33.414,56
0,00%
DAX
19.628,34
0,00%
S&P 500
6.032,38
0,56%
NASDAQ
19.218,17
0,83%
Bitcoin
96.006,30
-1,29%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE Cox Comm CL A SC23 (COX) Cox Comm CL A SC23 (COX) Notizie

COX

Cox Communications (COX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:COX
DataOraFonteTitoloSimboloCompagnia
15/06/201515:50Dow Jones NewsCox Automotive to Buy Dealertrack for $3.5 BillionNYSE:COXCox Comm CL A SC23
28/04/201500:10Dow Jones NewsTime Warner Cable Adviser Contacts Rival Cox--UpdateNYSE:COXCox Comm CL A SC23
17/04/201507:42GlobeNewswire Inc.Nicox first quarter 2015 financial and business updateNYSE:COXCox Comm CL A SC23
30/03/201507:40GlobeNewswire Inc.Nicox 2014 Financial Results and Business UpdateNYSE:COXCox Comm CL A SC23
19/03/201507:37GlobeNewswire Inc.Nicox receives Orphan Drug Designation from FDA for naproxcinod in Duchenne Muscular DystrophyNYSE:COXCox Comm CL A SC23
02/02/201507:41GlobeNewswire Inc.Nicox signs exclusive license agreement with InSite Vision for AzaSite(R) and BromSite(TM) in EuropeNYSE:COXCox Comm CL A SC23
26/01/201507:35GlobeNewswire Inc.Nicox holds successful pre-NDA meeting with FDA on AC-170 clinical packageNYSE:COXCox Comm CL A SC23
17/07/201407:36GlobeNewswire Inc.Nicox gains expanded North American rights for Sjo(TM) from Immco DiagnosticsNYSE:COXCox Comm CL A SC23
10/07/201407:35GlobeNewswire Inc.Nicox focuses US operations on national launches of Sjo(TM) and RetnaGene(TM) and restructures RPS(R) licensing agreementNYSE:COXCox Comm CL A SC23
02/07/201407:38GlobeNewswire Inc.Nicox to acquire Aciex Therapeutics, Inc.NYSE:COXCox Comm CL A SC23
30/06/201407:36GlobeNewswire Inc.Nicox launches commercial operations in GermanyNYSE:COXCox Comm CL A SC23
19/06/201407:38GlobeNewswire Inc.Nicox and Sequenom announce the launch of expanded access to RetnaGene(TM) test portfolio in the U.S.NYSE:COXCox Comm CL A SC23
30/05/201407:35GlobeNewswire Inc.CORRECTED RELEASE - Nicox: Santen grants Eupharmed extension of exclusive rights to distribute Cationorm(R) in ItalyNYSE:COXCox Comm CL A SC23
28/05/201407:36GlobeNewswire Inc.Nicox: Santen grants Eupharmed extension of exclusive rights to distribute Cationorm(R) in ItalyNYSE:COXCox Comm CL A SC23
15/05/201417:49GlobeNewswire Inc.Nicox: first quarter 2014 financial informationNYSE:COXCox Comm CL A SC23
02/04/201407:41GlobeNewswire Inc.Nicox 2013 Financial Results and Business UpdateNYSE:COXCox Comm CL A SC23
17/03/201407:35GlobeNewswire Inc.Nicox launches AdenoPlus(R) and Xailin(TM) dry eye product range in EuropeNYSE:COXCox Comm CL A SC23
14/02/201407:34GlobeNewswire Inc.Nicox to re-focus naproxcinod on Duchenne muscular dystrophyNYSE:COXCox Comm CL A SC23
04/02/201407:41GlobeNewswire Inc.Nicox appoints Evelyne Nguyen as CFONYSE:COXCox Comm CL A SC23
16/01/201407:37GlobeNewswire Inc.Sequenom Laboratories grants Nicox exclusive promotion and marketing rights for its RetnaGene(TM) AMD test in North AmericaNYSE:COXCox Comm CL A SC23
06/01/201423:39Dow Jones NewsConvergys Agrees to Acquire Stream Global ServicesNYSE:COXCox Comm CL A SC23
06/01/201407:34GlobeNewswire Inc.Nicox - Major Progress in 2013 in Building an International Ophthalmic CompanyNYSE:COXCox Comm CL A SC23
03/12/201314:56Dow Jones NewsCharter Communications Doesn't Need To Make Buys, CEO Says--UpdateNYSE:COXCox Comm CL A SC23
03/12/201314:37Dow Jones NewsCharter CEO: Charter Doesn't Need Acquisitions to Be Successful -CNBCNYSE:COXCox Comm CL A SC23
26/11/201307:50GlobeNewswire Inc.Nicox establishes commercial operations in Italy through acquisition of EupharmedNYSE:COXCox Comm CL A SC23
12/11/201307:48GlobeNewswire Inc.Nicox launches Sjo(TM) in the US and partners with the Sjogren's Syndrome FoundationNYSE:COXCox Comm CL A SC23
04/11/201307:35GlobeNewswire Inc.Nicox holds first ophthalmology Scientific Advisory Board and attends AAO 2013NYSE:COXCox Comm CL A SC23
30/10/201307:33GlobeNewswire Inc.Nicox reports financial results for the nine months to September 2013NYSE:COXCox Comm CL A SC23
27/09/201314:12GlobeNewswire Inc.Nicox attends Vision Expo West 2013 in Las VegasNYSE:COXCox Comm CL A SC23
11/09/201307:37GlobeNewswire Inc.Nicox Receives Positive Opinion for European Orphan Drug Designation for Naproxcinod for the Treatment of Duchenne Muscular D...NYSE:COXCox Comm CL A SC23
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:COX

La tua Cronologia

BIT
11COV
Covestro
BIT
18TRA
Traton
BIT
19MW
Marvell Technology
BIT
1A
Agilent Technologies
BIT
1AA
Alcoa
BIT
1AAD
Amadeus Fire
BIT
1AAG
Aumann
BIT
1AAL
American Airlines
BIT
1AAPL
Apple
BIT
1ABBV
Abbvie
BIT
1ABI
Anheuser Busch InBev SA NV
BIT
1ABNB
Airbnb
BIT
1ACA
Credit Agricole
BIT
1ACS
ACS Actividades de Const...
BIT
1AD
Koninklijke Ahold Delhai...
BIT
1ADBE
Adobe
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network